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Measles outbreaks in 1999 in Queensland and Victoria, Austra-
lia, were caused by a novel strain of clade G virus (proposed
name g3). Epidemiologic and molecular evidence supports
independent circulation of this virus in Queensland, northern
Australia, in addition to importation of the virus by East Timor
refugees seeking safe haven in Australia.
trategies to reduce Measles virus (MeV) circulation in
industrialized countries, such as aggressive vaccination
campaigns targeting children, have proven successful (1).
Nevertheless, through introduction from other geographic
locations, the virus continues to cause outbreaks in industrial-
ized countries in unvaccinated persons. 
In Victoria, measles is a reportable disease, and an
enhanced surveillance strategy has been operational since
1997. A registered nurse visits the homes of patients with
reported cases to collect specimens for laboratory confirma-
tion, by polymerase chain reaction or detection of MeV-spe-
cific immunoglobulin (Ig) M, of the clinical diagnosis and
subsequent identification of the measles genotype (2). For
other Australian states, specimens from laboratory-confirmed
cases are sent for genotyping to the WHO regional measles
reference laboratory for the western Pacific Region.
Variable regions in the MeV genome include the hemag-
glutinin (H) and nucleoprotein (N) genes. The most variable
region is the carboxyl-terminal end (450 nucleotides [nt]) of
the N gene. A uniform nomenclature approved by World
Health Organization (WHO) has existed since 1998 and is
used in classifying and naming measles viruses. Currently, 20
genotypes and 1 proposed new genotype exist, encompassing
eight clades designated A–H. Each clade contains MeV geno-
types that are related by >2.5% nt divergence in the 450-bp
carboxyl-terminal end of the N gene and 2% in the H gene (3).
Clades are distinguished by greater nucleotide differences,
location of nucleotides, and specific nucleotides shared in gen-
otypes of a particular clade.
Until recently, MeV strains belonging to clade G had not
been detected for >15 years, and the lineage was considered to
be either extinct or inactive (4). However, retrospective
sequence analysis of a measles strain isolated from an immu-
nocompromised infant from the Netherlands, who had been
infected in Indonesia in 1997, and of measles strains associ-
ated with outbreaks in Indonesia and Malaysia in 1999 have
demonstrated that this genotype has circulated in the interven-
ing period (5–6). We describe the circulation of a novel geno-
type of MeV in Australia and investigate its likely origin. 
The Study
In June 1999, the novel genotype was first identified in
Victoria in a 24-year-old Australian man who had symptoms
of MeV infection shortly after visiting the northern state of
Queensland. In the next 2 months, four more cases of infection
with the same genotype were identified in Queensland. Epide-
miologic links between these five cases could not be estab-
lished.
In the second week of September 1999, refugees from the
newly independent country of East Timor arrived in Darwin,
Northern Territory, where they underwent preliminary medical
examinations before being moved to a safe-haven refugee
camp in regional Victoria. Several days after arriving at the
safe haven, a 4-year-old girl had symptoms that matched the
clinical case definition of measles infection (rash and cough
with fever at onset of rash) (7). The diagnosis was confirmed
serologically with an Enzygnost Anti-measles-virus/IgM kit
(Dade Behring, Marburg, Germany). Active surveillance of all
contacts of the initial patient and all residents reporting to the
safe-haven medical center with symptoms suggestive of mea-
sles infection identified 11 other cases (4 laboratory con-
firmed) in children <13 years of age in the safe haven; a 26-
year-old volunteer worker who worked at the accident and
emergency department of the same hospital that admitted
some of the infected refugees was also diagnosed with measles
infection. Subsequent molecular analysis confirmed the volun-
teer’s infection as being caused by the same virus as the refu-
gees. The last recognized case of this MeV genotype occurred
in early November 1999, when a United Nations International
Force East Timor (Interfet) soldier, who showed clinical symp-
toms in East Timor immediately before he was transferred to
Darwin, was confirmed as being infected with MeV.
The commonality of the virus strains circulating in both
Australia and East Timor was confirmed through analysis of
MeV RNA (8). Analysis of the 456-bp carboxyl-terminal
region of the N gene of the Victorian and Queensland samples
yielded identical sequences in most cases, suggesting that
these patients were infected with the same strain of MeV as the
East Timorese. Nevertheless, no epidemiologic links were
apparent between the Queensland cases and the subsequent
cases in East Timorese refugees.
The N gene sequences of measles viruses identified from
June to November 1999 were most closely related to the
Amsterdam prototype G2 strain identified by de Swart et al.
(4). Although phylogenetic analysis indicated that these
sequences belonged within the clade G viruses, they differed
from the G2 prototype strain by 12 (2.6%) nt and by deduction
6 (4%) amino acids (Figure). N gene sequences were obtained
from 17 clinical samples. As a group, these 17 samples shared
an amino acid (439K) in the N protein not previously seen in
any other reference prototypes analyzed. Thirteen of these
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samples were identical in sequence (samples 1–13, Table).
Three samples (samples 14–16, Table) differed by a single
nucleotide, which resulted in another novel amino acid
change, P456L. One sample (sample 17, Table) diverged by 2
nt, one silent and the other resulting in the same P456L change
seen in samples 14–16. Differences seen in these 17 samples
did not appear to be related to the geographic location of the
cases.
Full or partial H gene sequences were derived from the
measles viruses of four samples obtained from patients 8, 13,
15, and 16. Phylogenetic analysis of the H gene of the first 842
nt of these samples confirmed their assignment to the clade G
viruses (results not shown). The four sequences analyzed
showed up to 1.1% intranucleotide divergence. The MeV from
patient 8 varied by 2.1% nt sequence compared with the proto-
type G2 strain. Comparison of nucleotide and amino acid
sequence of the H gene of the one sample (from patient 13)
with full H gene sequence showed differences from the proto-
type G2 strain of 35 (1.9%) nt and 13 (2.1%) amino acids. This
sequence also contained amino acids in the H protein not pre-
viously found in other reference prototypes, namely 212Q,
225H, 238D, and 495N. Phylogenetic analysis of the full H
gene sequence showed similar patterns of relatedness to those
obtained for the N gene (results not shown).
Together, phylogenetic analysis of the N and H genes and
the appearance of novel amino acids in the H protein provided
strong evidence that these measles virus were sufficiently
unrelated to the prototype G2 strain to enable their classifica-
tion as a new genotype within clade G. We propose that mea-
sles virus/Vic.AU/24.99 be the reference sequence for a new
genotype, g3, pending isolation of a reference strain (3). Gen-
Bank accession numbers for the 456-bp carboxyl-terminal end
of three of the N gene sequences are shown in the Table. The
GenBank accession number for the full-length H gene is
AF35362.
The novel g3 MeV was not the only strain circulating in
Australia during this time. Coinciding with the genotype g3
outbreak, four cases of genotype D8 were identified in Victo-
ria. Three months earlier, small clusters of measles cases were
identified in two other Australian states, genotype D5 in the
Northern Territory and genotype D3 in Western Australia.
Soon after the g3 outbreak, genotype D7 circulated in Victoria,
Queensland, and the Northern Territory.
In recent years, vaccination campaigns have been under-
taken in East Timor under the guidance of United Nations
Children’s Fund (UNICEF) and WHO. In October 1999,
UNICEF conducted a major immunization campaign in Dili,
East Timor, reaching approximately 4,000 children <5 years of
age; in March 2000, >45,000 children were vaccinated (9).
Nevertheless, from January 2000 to May 2001, a total of 1,479
cases of suspected measles infection were reported in East
Timor.
In an industrialized country like Australia, where no appar-
ent circulation of an indigenous MeV strain occurs, the use of
epidemiologic surveillance and molecular characterization is
important in tracing the source and transmission pathways of
MeV imported from areas where the disease is endemic. Apart
from expanding our global knowledge of MeV genotypes,
molecular characterization is also useful in clarifying epidemi-
ologic links and distinguishing between vaccine-associated
and wild-type infection.
Despite the novelty of the circulating MeV genotypes, our
findings highlight the need for continued vigilance if the virus
Figure. Phylogenetic analysis with the Phylip software program of DNA-
dist (maximum likelihood/neighbor-joining, 1000 bootstrap cycles) of
the carboxyl-terminal 456-bp nucleoprotein (N) gene sequence of mea-
sles virus/Vic.AU/24.99 circulating in Australia and East Timor. World
Health Organization–designated prototype strains are shown in bold,
and the proposed new g3 genotype is shown in bold and underlined.
Jakarta 1999 (G2) has also been included to show the difference
between the clade G viruses. Statistically significant bootstrap values
(>80%) are indicated. Scale (0.01) indicates nucleotide substitutions
per site.
Table. Unique predicted amino acid differences compared with all 
reference measles virus sequences in 456-bp carboxyl-terminal end 
of Na geneb
Sample no. Predicted amino acid differences  Accession no.
1–13 439Kc AF353622
14–16 439Kc; 456L AY055850
17 439Kc; 456L AY055851
aN, nucleoprotein.
bIdentified from 17 clinical samples in the outbreak.
cUnique to proposed genotype g3. Emerging Infectious Diseases  •  Vol. 8, No. 7, July 2002 737
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is to be eradicated. The humanitarian movement of refugees
from a country where MeV infection is uncontrolled to coun-
tries with relatively high MeV herd immunity is now a com-
mon occurrence. Thus, the potential for transmission of this
highly infectious virus to residual susceptibles in the wider
community remains a distinct possibility, as demonstrated by
this outbreak. Measures, such as vaccination of military per-
sonnel and support staff working directly with displaced per-
sons; use of appropriate infection-control procedures when
attending sick refugees; and screening of newly arrived refu-
gees from measles-endemic areas, are likely to decrease trans-
mission of MeV in industrialized countries.
Acknowledgments
We thank Stephen Lambert, David Smith, and Robyn Wood for
their assistance with provision of clinical material and epidemiologic
information.
Ms. Chibo is a medical scientist at the Victorian Infectious Dis-
eases Reference Laboratory in Victoria, Australia. Her main interests
are the use of molecular techniques and phylogenetic analysis to
study viruses of public health importance and mechanisms associated
with development of resistance to antiviral drugs by herpesviruses.
References
1. World Health Organization. Measles. Progress towards global control and
regional elimination 1998–1999. Wkly Epidemiol Rec 1999;74:429–40.
2. The Enhanced Measles Surveillance Working Party. Implementing a sys-
tem of enhanced surveillance for measles in Victoria. Commun Dis Intell
1999;23:51–4.
3. World Health Organization. Nomenclature for describing the genetic
characteristics of wild-type measles viruses. Wkly Epidemiol Rec
2001;76:242–7.
4. World Health Organization. Expanded programme on immunization—
standardization of the nomenclature for describing the genetic character-
istics of wild-type measles viruses. Wkly Epidemiol Rec 1998;73:265–9.
5. de Swart RL, Wertheim-van Dillen PME, van Binnendijk RS, Muller CP,
Frenkel J,  Osterhaus ADME. Measles in a Dutch hospital introduced by
an immuno-compromised infant from Indonesia infected with a new virus
genotype. Lancet 2000;355:201–2.
6. Rota PA, Liffick S, Rosenthal S, Heriyanto B, Chua KB. Measles geno-
type G2 in Indonesia and Malaysia. Lancet 2000;355:1557–8.
7. Ferson MJ, Young LC, Robertson PW, Whybin LR. Difficulties in clinical
diagnosis of measles: proposal for a modified case definition. Med J Aust
1995;163:364–6.
8. Chibo D, Birch CJ, Rota PA, Catton MG. Molecular characterization of
measles viruses isolated in Victoria, Australia, between 1973 and 1998. J
Gen Virol 2000;81:2511–8.
9. World Health Organization. Background paper for Donors’ Meeting on
East Timor. Canberra, 14–15 June 2001. Dili, East Timor. World Health
Organization; 2001. Available from: URL: http://www.who.int/disasters/
repo/6979.doc
Address for correspondence: Christopher Birch, 10 Wreckyn St., North Mel-
bourne 3051, Victoria, Australia; fax: 61 3 9342 2666; e-mail:
chris.birch@mh.org.au
	




Please print your name and business 
address in the box and return by fax 
to 404-371-5449 or mail to
EID Editor
CDC/NCID/MS D61
1600 Clifton Road, NE
Atlanta, GA 30333
Moving? Please give us your new address (in the box) and print the number of your old mailing
label here______________
YES, I would like to receive Emerging Infectious Diseases.
The print journal is available at no charge to public health professionals